Balancing brain chemicals for boosting meta-control

CHEMCONTROL aims to redefine cognitive control by exploring meta-level decision-making between dopamine and serotonin strategies to enhance adaptability and resilience in dynamic environments.

Subsidie
€ 2.625.000
2023

Projectdetails

Introduction

Cognitive control enables us to flexibly adapt behaviour to achieve our goals given a constantly changing environment. It is a hallmark of the human mind and exquisitely vulnerable in health and disease. Cognitive control often implies goal-directed instrumental effort to inhibit unwanted, yet hardwired or overlearnt biases, and is commonly associated with the prefrontal cortex (PFC) and dopamine (DA).

Importance of Cognitive Control

However, the mechanisms of the broader construct of flexible cognitive control remain unclear. The urgency of addressing this is evidenced by robust predictive associations between flexible control and consequential life outcomes for health, wealth, and well-being.

CHEMCONTROL Approach

CHEMCONTROL approaches the problem from a novel angle, reconceptualizing it as meta-level decision-making between distinct control strategies. I propose to shift attention away from the classic focus on instrumental effort, implicating PFC and DA, towards a richer meta-control framework that takes into account outcome controllability.

Redefining PFC Function

CHEMCONTROL radically upgrades the value of an opponent, cognitively effortless strategy that releases hardwired Pavlovian biases, implicating serotonin (5-HT). It redefines PFC function as making meta-level decisions between expensive dopaminergic versus frugal serotonergic strategies based on estimating outcome controllability.

Methodology

We have recently validated a computational procedure for quantifying controllability estimates. I will combine this procedure with:

  1. High-resolution fMRI to compare neural activity in DA and 5-HT systems.
  2. Novel PET designs to compare DA and 5-HT release.
  3. Psychopharmacology to causally manipulate key model components.
  4. Ultrasound neuromodulation to further investigate the mechanisms.

Conclusion

CHEMCONTROL will unravel the mechanisms of (boosting) meta-control, revolutionizing strategies for promoting efficacy and resilience in a rapidly changing world.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.625.000
Totale projectbegroting€ 2.625.000

Tijdlijn

Startdatum1-4-2023
Einddatum31-3-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Cross-species Regulation of Action by Controllability: a Keystone of 5-HT signalling?

This project aims to investigate the role of serotonin neurons in controllability estimation and its impact on behavior in health and depression, using advanced computational and neuroimaging techniques.

€ 1.483.738
ERC Starting...

Combinatorial neuromodulation of internal states

This project aims to investigate how combinations of neuromodulators influence neuronal dynamics and circuit configurations in the hippocampus-prefrontal circuit during various behavioral states in mice.

€ 1.499.563
ERC Starting...

Cease or Persist: A multivariate mechanistic account of effortful persistence

The COPE project aims to develop a neuro-computational model of effortful persistence to understand decision-making in neuropsychiatric disorders and improve treatment personalization.

€ 1.500.000
ERC Consolid...

Neuromodulatory control of brain network dynamics

This project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience.

€ 1.999.438
ERC Starting...

Feedback-control of the Microenvironment: Modular Organ-on-Chip Technology to elucidate the role of Neurovascular Stress in Schizophrenia

CHIPzophrenia aims to develop a feedback-controlled organ-on-chip system to study nitrosative stress effects on the blood-brain barrier, enhancing in-vitro research for schizophrenia and related disorders.

€ 1.499.375

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation

META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.

€ 2.987.655